Literature DB >> 27743168

MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.

X Ding1, Y Yang2, Y Sun3, W Xu1, B Su4, X Zhou5.   

Abstract

PURPOSE: To investigate the role of miR-585 in the development and progression of non-small-cell lung cancer (NSCLC).
METHODS: The expression levels of miR-585 in NSCLC cell lines and clinical samples were measured by quantitative PCR. NSCLC cells, A549 and H1299, were stably transfected with lentiviral vectors of miR-585 mimics or negative control. The effects of miR-585 on cell proliferation were detected both in vitro and in vivo. Cell migration and invasion were evaluated using wound healing assay and Transwell assay. Furthermore, luciferase reporter assay was used to identify the direct regulation of hSMG-1 by miR-585.
RESULTS: Our results showed that miR-585 was downregulated in NSCLC cell lines and tumor tissues. Ectopic expression of miR-585 inhibited the ability of cell proliferation, migration, and invasion in vitro. In addition, miR-585 also decreased the growth rate of xenografted tumor in nude mice. Mechanically, miR-585 directly targeted the 3'-untranslated region (UTR) of hSMG-1 gene, which likely resulted in a dysfunction of mRNA surveillance and nonsense-mediated mRNA decay.
CONCLUSION: Taken together, miR-585 probably has an inhibitory effect on tumor growth and is a prognostic biomarker of NSCLC.

Entities:  

Keywords:  Invasion; Non-small-cell lung cancer; Proliferation; hSMG-1; miR-585

Mesh:

Substances:

Year:  2016        PMID: 27743168     DOI: 10.1007/s12094-016-1562-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  19 in total

Review 1.  The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways.

Authors:  Robert T Abraham
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

2.  Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay.

Authors:  David R McIlwain; Qun Pan; Patrick T Reilly; Andrew J Elia; Susan McCracken; Andrew C Wakeham; Annick Itie-Youten; Benjamin J Blencowe; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

3.  Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Authors:  Santosh K Patnaik; Eric Kannisto; Steen Knudsen; Sai Yendamuri
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

4.  The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.

Authors:  Atsushi Uesugi; Ken-Ichi Kozaki; Tomohiko Tsuruta; Mayuko Furuta; Kei-Ichi Morita; Issei Imoto; Ken Omura; Johji Inazawa
Journal:  Cancer Res       Date:  2011-07-27       Impact factor: 12.701

5.  Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay.

Authors:  A Yamashita; T Ohnishi; I Kashima; Y Taya; S Ohno
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  MicroRNA signature predicts survival and relapse in lung cancer.

Authors:  Sung-Liang Yu; Hsuan-Yu Chen; Gee-Chen Chang; Chih-Yi Chen; Huei-Wen Chen; Sher Singh; Chiou-Ling Cheng; Chong-Jen Yu; Yung-Chie Lee; Han-Shiang Chen; Te-Jen Su; Ching-Cheng Chiang; Han-Ni Li; Qi-Sheng Hong; Hsin-Yuan Su; Chun-Chieh Chen; Wan-Jiun Chen; Chun-Chi Liu; Wing-Kai Chan; Wei J Chen; Ker-Chau Li; Jeremy J W Chen; Pan-Chyr Yang
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 7.  MicroRNAs in the pathogenesis of Lung Cancer.

Authors:  Xin Wu; Melissa G Piper-Hunter; Melissa Crawford; Gerard J Nuovo; Clay B Marsh; Gregory A Otterson; Serge P Nana-Sinkam
Journal:  J Thorac Oncol       Date:  2009-08       Impact factor: 15.609

Review 8.  MicroRNAs as lung cancer biomarkers.

Authors:  Valerio Del Vescovo; Margherita Grasso; Mattia Barbareschi; Michela A Denti
Journal:  World J Clin Oncol       Date:  2014-10-10

9.  A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosis.

Authors:  Vasco Oliveira; William J Romanow; Christoph Geisen; Diane M Otterness; Frank Mercurio; Hong Gang Wang; William S Dalton; Robert T Abraham
Journal:  J Biol Chem       Date:  2008-03-06       Impact factor: 5.157

10.  MicroRNAs and cancer: short RNAs go a long way.

Authors:  Andrea Ventura; Tyler Jacks
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  9 in total

1.  [Specific microRNA expression profiles of lung adenocarcinoma in Xuanwei region and bioinformatic analysis for predicting their target genes and related signaling pathways].

Authors:  Shuai Chen; Yong-Chun Zhou; Ying Chen; Xiao-Bo Chen; Guang-Jian Li; Jia-Peng Yang; Yu-Jie Lei; Guang-Qiang Zhao; Qiu-Bo Huang; Chang-Shao Yang; Ya-Xi DU; Yun-Chao Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  MicroRNA-585 inhibits human glioma cell proliferation by directly targeting MDM2.

Authors:  Wangsheng Chen; Lan Hong; Changlong Hou; Yibin Wang; Fei Wang; Jianhua Zhang
Journal:  Cancer Cell Int       Date:  2020-09-29       Impact factor: 5.722

3.  Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.

Authors:  Yiming Jia; Jingru Li; Jinfeng Wang; Tianjiao Luo; Xiaoqian Jing; Hongmin Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2022-05-13       Impact factor: 4.133

4.  Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis.

Authors:  Rizeng Li; BinBin Wu; Jianfu Xia; Lechi Ye; Xiaoping Yang
Journal:  Cancer Manag Res       Date:  2019-07-23       Impact factor: 3.989

5.  Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3.

Authors:  Chunmei Liu; Juan Yang; Han Wu; Jun Li
Journal:  Onco Targets Ther       Date:  2019-08-14       Impact factor: 4.147

6.  Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.

Authors:  Yumei Qi; Yo-Liang Lai; Pei-Chun Shen; Fang-Hsin Chen; Li-Jie Lin; Heng-Hsiung Wu; Pei-Hua Peng; Kai-Wen Hsu; Wei-Chung Cheng
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  MiR-585-5p impedes gastric cancer proliferation and metastasis by orchestrating the interactions among CREB1, MAPK1 and MITF.

Authors:  Yunwei Wang; Ming Li; Jiaoxia Zeng; Yunshu Yang; Zengshan Li; Sijun Hu; Fangfang Yang; Na Wang; Wenlan Wang; Jun Tie
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

8.  Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity.

Authors:  Jing Ai; Junhui Sun; Guanhui Zhou; Tongyin Zhu; Li Jing
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

9.  Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression.

Authors:  Chan Zhang; Shangjie Wu; Rong Song; Changming Liu
Journal:  Aging (Albany NY)       Date:  2020-08-07       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.